Heng Du

1.7k total citations
74 papers, 1.1k citations indexed

About

Heng Du is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, Heng Du has authored 74 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 19 papers in Physiology. Recurrent topics in Heng Du's work include Tuberous Sclerosis Complex Research (15 papers), Lung Cancer Diagnosis and Treatment (11 papers) and Vascular Tumors and Angiosarcomas (8 papers). Heng Du is often cited by papers focused on Tuberous Sclerosis Complex Research (15 papers), Lung Cancer Diagnosis and Treatment (11 papers) and Vascular Tumors and Angiosarcomas (8 papers). Heng Du collaborates with scholars based in China, United States and Switzerland. Heng Du's co-authors include Guowei Che, Shuangjiang Li, Jun Fan, David J. Kwiatkowski, Yubin Zhou, Jian Huang, Dali Chen, Lunxu Liu, Elizabeth P. Henske and Cheng Shen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Heng Du

67 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heng Du China 19 399 373 263 236 216 74 1.1k
Nisha Nanda United States 14 235 0.6× 561 1.5× 286 1.1× 137 0.6× 94 0.4× 33 1.4k
Thomas Dreyer Germany 20 461 1.2× 342 0.9× 270 1.0× 433 1.8× 94 0.4× 54 1.2k
Lavinia Maegel Germany 15 154 0.4× 609 1.6× 386 1.5× 271 1.1× 140 0.6× 27 1.2k
Annabelle Mahar Australia 19 310 0.8× 997 2.7× 163 0.6× 112 0.5× 243 1.1× 56 1.3k
Takeshi Yokoe Japan 20 777 1.9× 216 0.6× 507 1.9× 275 1.2× 156 0.7× 54 1.4k
Kiyotaka Nagahama Japan 24 177 0.4× 304 0.8× 467 1.8× 168 0.7× 186 0.9× 83 1.4k
Diana L. Hanna United States 17 600 1.5× 250 0.7× 238 0.9× 164 0.7× 66 0.3× 75 1.0k
Shiu-Feng Huang Taiwan 20 339 0.8× 292 0.8× 241 0.9× 431 1.8× 63 0.3× 42 1.1k
Mai Matsumura Japan 16 375 0.9× 358 1.0× 595 2.3× 241 1.0× 53 0.2× 57 1.3k
Qiuyuan Xia China 21 284 0.7× 641 1.7× 656 2.5× 168 0.7× 193 0.9× 74 1.2k

Countries citing papers authored by Heng Du

Since Specialization
Citations

This map shows the geographic impact of Heng Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng Du more than expected).

Fields of papers citing papers by Heng Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heng Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng Du. The network helps show where Heng Du may publish in the future.

Co-authorship network of co-authors of Heng Du

This figure shows the co-authorship network connecting the top 25 collaborators of Heng Du. A scholar is included among the top collaborators of Heng Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heng Du. Heng Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Heng, et al.. (2025). AF-MCDC: Active Feedback-Based Malicious Client Dynamic Detection. Computer Networks. 263. 111234–111234.
2.
3.
Du, Heng, et al.. (2025). Efficacy of stem cell therapy for diabetic kidney disease: a systematic review and meta-analysis. Frontiers in Medicine. 12. 1601900–1601900.
4.
Liu, Li, Yuan He, Heng Du, et al.. (2025). Biological profile of breast cancer brain metastasis. Acta Neuropathologica Communications. 13(1). 78–78. 1 indexed citations
5.
He, Li, Qingfeng Miao, Haibin Shi, et al.. (2024). Remote sensing monitoring of irrigated area in the non-growth season and of water consumption analysis in a large-scale irrigation district. Agricultural Water Management. 303. 109020–109020. 6 indexed citations
6.
Wagner, Andrew J., Vinod Ravi, Richard F. Riedel, et al.. (2024). Phase II Trial of nab-Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update. Journal of Clinical Oncology. 42(13). 1472–1476. 16 indexed citations
7.
8.
Hui, Jiaojiao, et al.. (2023). Inhibition of ferroptosis by POLE2 in gastric cancer cells involves the activation of NRF2/GPX4 pathway. Journal of Cellular and Molecular Medicine. 28(1). e17983–e17983. 7 indexed citations
9.
Liu, Heng-Jia, Heng Du, Damir Khabibullin, et al.. (2023). mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion. Nature Communications. 14(1). 1214–1214. 55 indexed citations
10.
Huang, Ronghua, et al.. (2023). A machine learning framework develops a DNA replication stress model for predicting clinical outcomes and therapeutic vulnerability in primary prostate cancer. Journal of Translational Medicine. 21(1). 20–20. 26 indexed citations
11.
Yang, Eddy S., Amin H. Nassar, Elio Adib, et al.. (2021). Gene Expression Signature Correlates with Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Everolimus Alone or with a Vascular Disrupting Agent. Molecular Cancer Therapeutics. 20(8). 1454–1461. 6 indexed citations
12.
Wang, Ji, Harilaos Filippakis, Heng Du, et al.. (2021). Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells. Proceedings of the National Academy of Sciences. 118(39). 17 indexed citations
13.
Fu, Song, Heng Du, Chrong‐Reen Wang, et al.. (2020). Evaluating the Performance of p16INK4a Immunocytochemistry in Cervical Cancer Screening. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Chen, Zhixin, et al.. (2020). Metabolic Syndrome Predicts Poor Outcome in Acute Ischemic Stroke Patients After Endovascular Thrombectomy. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Li, Shuangjiang, Hongyu Wang, Yang Zhang, et al.. (2020). Naples Prognostic Score as a novel prognostic prediction tool in video-assisted thoracoscopic surgery for early-stage lung cancer: a propensity score matching study. Surgical Endoscopy. 35(7). 3679–3697. 27 indexed citations
16.
Zarei, Mahsa, Heng Du, Amin H. Nassar, et al.. (2019). Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion. The Journal of Experimental Medicine. 216(11). 2635–2652. 17 indexed citations
17.
Du, Heng, et al.. (2019). Inhibition of both endplate nutritional pathways results in intervertebral disc degeneration in a goat model. Journal of Orthopaedic Surgery and Research. 14(1). 138–138. 23 indexed citations
18.
Huang, Jian, Yutian Lai, Ke Gao, et al.. (2017). Surfactant Protein-D: A sensitive predictor for efficiency of preoperative pulmonary rehabilitation. International Journal of Surgery. 41. 136–142. 8 indexed citations
19.
20.
Lai, Yutian, Heng Du, Cheng Shen, et al.. (2016). Status and Perspectives of Clinical Modes in Surgical Patients With Lung Cancer. Medicine. 95(2). e2429–e2429. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nisha Nanda Breakdown of academic impact, for papers by Thomas Dreyer Breakdown of academic impact, for papers by Lavinia Maegel Breakdown of academic impact, for papers by Annabelle Mahar Breakdown of academic impact, for papers by Takeshi Yokoe Breakdown of academic impact, for papers by Kiyotaka Nagahama Breakdown of academic impact, for papers by Diana L. Hanna Breakdown of academic impact, for papers by Shiu-Feng Huang Breakdown of academic impact, for papers by Mai Matsumura Breakdown of academic impact, for papers by Qiuyuan Xia
Rankless by CCL
2026